These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27585679)

  • 1. Desensitization protocol enabling pediatric crossmatch-positive renal transplantation: successful HLA-antibody-incompatible renal transplantation of two highly sensitized children.
    Adamusiak AM; Stojanovic J; Shaw O; Vaughan R; Sebire NJ; Drage M; Kessaris N; Marks SD; Mamode N
    Pediatr Nephrol; 2017 Feb; 32(2):359-364. PubMed ID: 27585679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desensitization protocol in highly HLA-sensitized and ABO-incompatible high titer kidney transplantation.
    Uchida J; Machida Y; Iwai T; Naganuma T; Kitamoto K; Iguchi T; Maeda S; Kamada Y; Kuwabara N; Kim T; Nakatani T
    Transplant Proc; 2010 Dec; 42(10):3998-4002. PubMed ID: 21168610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients.
    Al Meshari K; Pall A; Chaballout A; El Gamal H; Al Mana H; Humaidan H; Alzayer F; Al Talhi M
    Transplant Proc; 2013 May; 45(4):1423-6. PubMed ID: 23726587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case Report: Successful Living Donor Kidney Transplantation in a Highly Human Leukocyte Antigen-Sensitized Recipient With a Positive Cytotoxic Crossmatch Using Bortezomib-Based Desensitization Without Intravenous Immunoglobulin.
    Revollo JY; Cuffy MC; Abu Jawdeh BG; Paterno F; Girnita A; Brailey P; Alloway RR; Woodle ES
    Transplant Proc; 2015 Sep; 47(7):2254-7. PubMed ID: 26361693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of a multicenter prospective clinical study in Japan for evaluating efficacy and safety of desensitization protocol based on rituximab in ABO-incompatible kidney transplantation.
    Takahashi K; Saito K; Takahara S; Fuchinoue S; Yagisawa T; Aikawa A; Watarai Y; Yoshimura N; Tanabe K; Morozumi K; Shimazu M;
    Clin Exp Nephrol; 2017 Aug; 21(4):705-713. PubMed ID: 27534951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney transplant in highly sensitized patients after desensitization with plasmapheresis and low-dose intravenous immunoglobulin.
    Yuan XP; Wang CX; Gao W; Fu Q; He XS
    Exp Clin Transplant; 2010 Jun; 8(2):130-5. PubMed ID: 20565369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney transplantation across HLA and ABO antibody barriers.
    Becker LE; Süsal C; Morath C
    Curr Opin Organ Transplant; 2013 Aug; 18(4):445-54. PubMed ID: 23838650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desensitization protocols for prospective pediatric renal transplant recipients.
    Mamode N; Marks SD
    Pediatr Nephrol; 2016 Oct; 31(10):1549-51. PubMed ID: 27270722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience.
    Jin MK; Cho JH; Kwon O; Hong KD; Choi JY; Yoon SH; Park SH; Kim YL; Kim CD
    Transplant Proc; 2012 Jan; 44(1):200-3. PubMed ID: 22310614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABO-incompatible matching significantly enhances transplant rates in kidney paired donation.
    Ferrari P; Hughes PD; Cohney SJ; Woodroffe C; Fidler S; D'Orsogna L
    Transplantation; 2013 Nov; 96(9):821-6. PubMed ID: 23860086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome after Desensitization in HLA or ABO-Incompatible Kidney Transplant Recipients: A Single Center Experience.
    Kauke T; Klimaschewski S; Schoenermarck U; Fischereder M; Dick A; Guba M; Stangl M; Werner J; Meiser B; Habicht A
    PLoS One; 2016; 11(1):e0146075. PubMed ID: 26730981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desensitization in HLA-incompatible kidney recipients and survival.
    Montgomery RA; Lonze BE; King KE; Kraus ES; Kucirka LM; Locke JE; Warren DS; Simpkins CE; Dagher NN; Singer AL; Zachary AA; Segev DL
    N Engl J Med; 2011 Jul; 365(4):318-26. PubMed ID: 21793744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of sensitized pediatric patients prior to renal transplantation.
    Pirojsakul K; Desai D; Lacelle C; Seikaly MG
    Pediatr Nephrol; 2016 Oct; 31(10):1691-8. PubMed ID: 26801944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bortezomib in ABO-incompatible kidney transplant desensitization: a case report.
    Wong NL; O'Connell P; Chapman JR; Nankivell B; Kable K; Webster AC; Wong G
    Nephrology (Carlton); 2015 Mar; 20 Suppl 1():22-4. PubMed ID: 25807854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Panel-reactive antibody levels and renal transplantation rates in sensitized patients after desensitization and human leucocyte antigen amino acid residue matching.
    Shang W; Dong L; Feng G; Wang Y; Pang X; Li J; Liu L; Zhang W
    J Int Med Res; 2013 Aug; 41(4):1333-41. PubMed ID: 23780877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful Transplantation in ABO- and HLA-Incompatible Living Kidney Transplant Patients: A Report on 12 Cases.
    Rostaing L; Karam B; Congy-Jolivet N; Hage V; Sallusto F; Esposito L; Doumerc N; Debiol B; Guilbeau-Frugier C; Game X; Allal A; Kamar N
    Ther Apher Dial; 2016 Oct; 20(5):507-516. PubMed ID: 27073167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of Total Lymphoid Irradiation, Low-Dose IVIG and ATG as Rescue Therapy for Highly Sensitized and Antibody-Mediated Rejection Renal Transplant Recipients.
    Zhu D; Qi G; Tang Q; Li L; Yang C; Lin M; Wu B; Xu M; Cai J; Zhu T; Rong R
    Clin Transpl; 2014; ():215-21. PubMed ID: 26281148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches.
    Yamanaga S; Watarai Y; Yamamoto T; Tsujita M; Hiramitsu T; Nanmoku K; Goto N; Takeda A; Morozumi K; Katayama A; Saji H; Uchida K; Kobayashi T
    Hum Immunol; 2013 Sep; 74(9):1111-8. PubMed ID: 23792054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desensitization strategies enabling successful renal transplantation in highly sensitized patients.
    Beimler JH; Susal C; Zeier M
    Clin Transplant; 2006; 20 Suppl 17():7-12. PubMed ID: 17100695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Approaches to Desensitization in Solid Organ Transplantation.
    Schinstock C; Tambur A; Stegall M
    Front Immunol; 2021; 12():686271. PubMed ID: 34046044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.